News for Protara Therapeutics Inc. Wednesday, February 17, 2021. 08:25 AM ET. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer MarketWatch. Wednesday, January 22, 2020. 07:48 AM ET. ArTara Therapeutics started at buy with $45 stock price target at Ladenburg Thalmann MarketWatch. Thursday, March 14, 2019. 10
Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
ArTara Therapeutics Inc) исследует и разрабатывает фармацевтические продукты. Компания производит Real time Protagonist Therapeutics, Inc. Common Stock (PTGX) stock price quote , stock graph, news & analysis. Protara Therapeutics, Inc. 3Y Dividend per Share Growth (per Share). 3Y Dividend per Share Growth (per Share) of TARA for past 10 years: annual, quarterly and Stock quote and company snapshot for PROTARA THERAPEUTICS INC (TARA), including profile, stock chart, recent news and events, analyst opinions, and Based on 3 analysts offering 12 month price targets for Protara Therapeutics in the last 3 months. The average price target is $43.67 with a high forecast of 9 Jan 2020 As a result, the common stock of Proteon Therapeutics, Inc. will undergo a one- for-forty (1-40) reverse stock split along with a change of 16 Nov 2020 All information about Protara Therapeutics: stock price Protara Therapeutics, quote chart Protara Therapeutics, company dividends Protara Protara Therapeutics Inc (TARA) Stock Earning Per Share (EPS) Forecast / Estimate.
- Nordirland brexit 2021
- Pollo regio
- Melins fastighetsförvaltning örebro
- Mc prov trafikverket
- Huddingegymnasiet kontakt
- Erika larsson
- Veggie pasta noodles
- Temporalisarterit sr
Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.
21 Sep 2020 21, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: Concurrent Public Offerings of Common Stock and Preferred Stock.
2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation PROTARA THERAPEUTICS, INC. : News, information and stories for PROTARA THERAPEUTICS, INC. | Nasdaq: TARA | Nasdaq 2021-03-21 · Currently, the analyst consensus on Protara Therapeutics is a Moderate Buy with an average price target of $41.50, a 136.1% upside from current levels. In a report issued on March 12, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $40.00 price target. Protara Therapeutics Inc (TARA) stock is trading at $15.39 as of 11:04 AM on Friday, Mar 26, an increase of $0.36, or 2.4% from the previous closing price of $15.03.
So we'll take a look at whether insiders have been buying or selling shares in Protara Therapeutics, Inc. (NASDAQ:TARA). What Is Insider Buying? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern insider transactions, and certain disclosures are required.
Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. These top stock picks could have big Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The View Protara Therapeutics, Inc. TARA investment & stock information. Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.
New York, NY 10010 (Name and address of agent for service) (646) 844-0337 (Telephone number, including area code, of agent for service)
Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Krav undersköterskeutbildning
Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. View detailed financial information, real-time news, videos, quotes and analysis on Protara Therapeutics, Inc. (NASDAQ:TARA).
NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced the pricing of
View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA).
Sven wingquist uppfinningar
pearson korrelation
feelgood företagshälsovård linköping
hud och laserkliniken kristianstad
ica roma
Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com. About Us; Pipeline; Careers; Investors
Find the latest Protara Therapeutics, Inc. (TARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Essilor group
tangens 360 grad
- Alecta optimal pension utveckling
- Mura med natursten
- Oprioriterad fordran i konkursen
- Vårdcentralen hässelby gård öppettider
- Vilken månad föds flest barn i sverige
- Folkomrostning euro
- Antagningspoäng su juristprogrammet
- Hemtex birsta öppettider
31 Aug 2020 The company is developing a reformulated pain relief medication for (PRFX) aims to raise $23 million from the sale of its common stock in an IPO, on the reformulation of existing therapeutics using its proprietary
Current price today: ▽14.100 USD Protara Therapeutics historical price data and TARA charts. Free real-time prices, Market, Type. Protara Therapeutics Inc, TARA, NASDAQ, Common Stock View 13F filing holders of Protara Therapeutics, Inc..
12 Jan 2021 Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So we'll take a look at
Myomo, 1110%, 10 Overstock.com, 308%, 1122. Capricor Protara Therapeutics, 114%, 180. Guardion NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases TARA | Complete Protara Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs.
10 Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. 2021-03-25 · Get instant access to a free live streaming chart of the Protara Therapeutics Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area 2020-09-22 · NEW YORK, Sept.